Besides, median pre-treatment rate of positive tumor cells for c-myc, Cyclin D1, and Zeb-1 were 30% (range 10–60%), 50% (15–60%), and 12% (5–25%), respectively. The gene discussed is CCND1; the disease is neoplasm.